Skip to main content

Practical strategies to improve CRC screening completion in primary care

CRC screening is one of the most effective tools for cancer prevention, yet national screening rates continue to fall short of recommended goals. Primary care visits play a central role in closing these gaps.

CRC screening: Awareness is high, completion is not

Most eligible adults today know that CRC screening exists and understand when screening should begin.1 However, completion often breaks down after the recommendation. 

Common patient-reported barriers:

  • Cost, access and logistical concerns, especially for colonoscopy¹

  • Discomfort, including stool handling, or anxiety about invasive procedures¹

  • Gaps in understanding screening options, including how different tests work and what results may indicate³
     

These challenges underscore the importance of having screening alternatives to meet patients where they are to help ensure that screening happens.

Provider recommendation, addressing patient hesitations, and ease of access all strongly influence whether patients start and complete screening.

Evolving CRC testing to fit real-world practice 

Today, effective CRC screening depends on more than clinical accuracy; it requires options that patients are willing to start and able to complete within real-world practice constraints.

Explore Labcorp’s flexible CRC screening options designed for primary care workflows:

ColoSense® offered by Labcorp

The first FDA-approved, multi-target stool-RNA (mt-sRNA) screening test that improves detection of CRC and advanced adenomas

  • Recommended every three years for adults age 45+ at average risk for CRC
  • Identifies biomarkers linked to CRC
  • Simplified at-home collection to support patient adherence 

ColoFIT® Home Collection Test

A simple at-home fecal immunochemical test (FIT)
 

  • Recommended annually for adults age 45+ at average risk for CRC
  • Detects hemoglobin in stool
  • Convenient option with in-office pickup/Labcorp patient service center return

A one-minute conversation can help boost CRC screening completion

Evidence shows that patients who decide on a CRC screening test with their provider are significantly more likely to complete screening.4

In busy clinics, effective conversations don’t need to require added burden.

Short, focused discussions, often under a minute, can:

  • Explain the benefits of early CRC detection

  • Review CRC screening options, including noninvasive options and colonoscopy

  • Help patients leave with a clear plan for completing screening


This approach supports best practices for CRC prevention while helping reduce repeat calls and delayed follow-up.

Supporting patients after the visit

Patients frequently leave visits with unresolved questions, which can delay or prevent screening completion, especially for stool-based tests.

Clear education supports informed decision making and helps patients stay engaged without adding strain to practice workflows.

Sharing patient‑friendly resources can help reinforce:

  • How CRC screening stool tests work

  • What screening results may indicate

  • Why completing screening on time matters

Frequently asked questions about CRC screening

You have the power to prevent colon cancer

Taking care of your long-term colon health is your choice. Your gut is trusting you to make the right one.

When colon cancer is found and removed before spreading, the chance of long-term remission is fantastic—around 90% of patients survive beyond 5 years! But if the cancer has spread outside the colon, the chance of living beyond 5 years drops to only about 15%.

Routine screening is key to preventing colon cancer deaths

People with early colon cancer may not have any symptoms. This is why routine screening is so important. Colon cancer can take as long as 10 to 15 years to develop, which gives you lots of time to do something about it. It’s important that you talk to your doctor and develop a colon cancer screening plan that is right for you. It could save your life.

60% An estimated 60% of colon cancer deaths are preventable if everyone follows screening guidelines
45 to 75 Colon cancer screening is recommended for everyone between the ages of 45 and 75—even if you don’t have symptoms
53% Screening tests can detect early cancer or precancerous changes long before these cause symptoms and while they are still easy to treat. Increased screening resulted in a 53% drop in colon cancer deaths from 1980 to 2017

You have options for colon cancer screening

You have probably heard about colonoscopy and what it entails, but did you know there are trusted at-home screening options for people of average risk? A fecal immunochemical test, or FIT, is a noninvasive test you can complete in the comfort of your own home. Labcorp offers convenient at-home stool-based CRC screening options that are designed to be flexible and meet your needs

ColoSense® offered by Labcorp*

The first FDA-approved, multi-target stool-RNA (mt-sRNA) screening test that is designed to detect CRC and advanced adenomas

  • Recommended every three years for adults age 45+ at average risk for CRC
  • Identifies biomarkers linked to CRC and for the presence of hemoglobulin in blood
  • Simplified at-home collection to support patient adherence 

The Labcorp ColoFIT kit makes at-home colon cancer screening an easy and trusted process

People are accomplishing more than ever before from the comfort of their own homes. You can work from home, shop from home, order groceries from home— why not screen for colon cancer at home, too? The Labcorp ColoFIT kit makes annual colon cancer screening a seamless and private process. Learn more about how Labcorp helps people at average risk for colon cancer take control of their colon health—from home!

Easy to use

Your FIT Kit comes with everything you need to collect and mail your sample to Labcorp

Small sample requirement

Only a 0.01-gram stool specimen is required to perform the FIT test—less than other at-home screening methods

Colon cancer resources

Read our blogs to learn about colon cancer screening - who should be screened, when to get screening, and if it's right for you.

Frequently asked questions about colon cancer

Have questions? Concerns? That’s okay. It’s not always possible to make time for all your questions during a doctor’s visit, so we’re here as a resource to answer questions you may have about colon cancer.

References

  1. Count on you, 2025 edition
  2. Siegel RL, Wagle NS, Jemal A. Leading cancer deaths in people younger than 50 years. JAMA. Published online January 22, 2026. doi:10.1001/jama.2025.25467
  3. Lin Y, Fan S, Chai W, et al. Barriers and facilitators to population participation in colorectal cancer screening: An umbrella review. BMC Health Serv Res. 2026;26:288. https://doi.org/10.1186/s12913-025-13879-z
  4. Krist AH, Hochheimer CJ, Sabo RT, et al. Patient, clinician, and communication factors associated with colorectal cancer screening. J Am Board Fam Med. 2020;33(5):779-784.